Supreme Court divided over legality of patent reviews

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Supreme Court divided over legality of patent reviews

Abbvie (ABBV) PT Raised to $93 at Citi; Remains sidelined

November 29, 2017 8:14 AM EST

Citi raised its price target on Abbvie (NYSE: ABBV) to $93.00 (from $60.00) while maintaining a Neutral rating. Citi upgraded EPS and TP to reflect a more optimistic base case for the timing of US Humira biosimilar entry. However, Citi is unable to become... More

Morgan Stanley Upgrades Allergen (AGN) to Overweight

November 29, 2017 4:16 AM EST

(Updated - November 29, 2017 6:56 AM EST)

(updated to add analyst comment)

Morgan Stanley upgraded Allergen (NYSE: AGN) from Equalweight to Overweight with a price target of $200.00.

Analyst David Risinger likes the attractive risk/reward following the recent decline in the... More